Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes.

http://www.wikidata.org/entity/Q36915945

about

Animal models of GM2 gangliosidosis: utility and limitations Hematopoietic stem cell and gene therapy corrects primary neuropathology and behavior in mucopolysaccharidosis IIIA mice.Myeloid/Microglial driven autologous hematopoietic stem cell gene therapy corrects a neuronopathic lysosomal disease Quality rather than quantity: the cord blood bank dilemma.The Mannheim Cord Blood Bank: Experiences and Perspectives for the Future.Influence of maternal, infant, and collection characteristics on high-quality cord blood units in Guangzhou Cord Blood Bank.A History of Cord Blood Banking and Transplantation Recommendations on clinical trial design for treatment of Mucopolysaccharidosis Type III.Current practices and prospects for standardization of the hematopoietic colony-forming unit assay: a report by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning.Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group.Stem cell microvesicles transfer cystinosin to human cystinotic cells and reduce cystine accumulation in vitro.Progenitor cell dose determines the pace and completeness of engraftment in a xenograft model for cord blood transplantation.Mucopolysaccharidosis I, II, and VI: Brief review and guidelines for treatment.Umbilical Cord Blood Banking for Transplantation in Morocco: Problems and opportunities.Early Umbilical Cord Blood-Derived Stem Cell Transplantation Does Not Prevent Neurological Deterioration in Mucopolysaccharidosis Type III.Umbilical cord blood banking: an update Long-term functional outcomes of children with hurler syndrome treated with unrelated umbilical cord blood transplantation.A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients.Umbilical cord blood: current status & promise for the future.Gene therapy for neurologic manifestations of mucopolysaccharidoses.Postthaw characterization of umbilical cord blood: markers of storage lesion Umbilical cord transplantation: epilogue Increased sensitivity for detecting malaria parasites in human umbilical cord blood using scaled-up DNA preparation.Unrelated hematopoietic stem cell transplantation in the pediatric population: single institution experience Variability in subjective review of umbilical cord blood colony forming unit assay.The Cord Blood Apgar: a novel scoring system to optimize selection of banked cord blood grafts for transplantation (CME).A perspective on the selection of unrelated donors and cord blood units for transplantation Neonatal Bone Marrow Transplantation in MPS IIIA Mice.AAV Gene Therapy for MPS1-associated Corneal Blindness Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies Optimizing donor selection for public cord blood banking: influence of maternal, infant, and collection characteristics on cord blood unit quality.Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases Activity of daily living for Morquio A syndrome.Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood.Long-Term Quality Control Program Plan for Cord Blood Banks in Korea: A Pilot Study for Cryopreservation Stability.Umbilical cord blood transplantation for non-malignant diseases.A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.The expanding frontier of hematopoietic cell transplantation.

P2860

Q26738663-9048C931-5270-476B-976B-71BCB20C6EB1 Q30524212-388EFE3A-ADAB-4265-99FB-B8BA41049F58 Q30554347-86272BF5-58A5-40C4-A1E3-26D368D410DA Q33452269-28317B5B-2BC3-49D9-AF6C-E9E802E67314 Q33452872-3CD0B9F2-A6D7-4111-9ABD-517309C69A24 Q33457345-D96E3AFE-6455-4500-A9B3-4699CC7ED748 Q33722088-3F85B139-43F6-4DD7-B3C8-12D806B65706 Q33837598-3E7C488E-E63F-4A3A-812A-D42C3E048416 Q33926045-BDB490BD-5058-490F-9935-05C82E70DF6F Q34256752-6B26DF80-6663-4CDC-BFC6-E863FB4C0EF3 Q34333060-3C4FCA4C-BFE9-4225-B45C-4325D8CC2CC8 Q34343785-5AFF1B4B-094C-4CD0-BE5F-2B7A691F22D4 Q34388980-012503F0-1202-4760-A579-84E41EFB29FF Q34541687-180E8D43-01C6-4EF7-91CC-6E78734F834C Q34562817-E2B03574-957B-4B49-A26B-8E9D83E5469B Q35086359-BFDB886B-D95F-499E-B6AD-D1D61F1FE100 Q35183102-694FDC37-774D-4A89-B281-09C3973F926B Q35205833-CF62B577-E362-4F37-9EF8-946D09CBC30B Q35220724-FAB7283C-E973-461A-9F85-E27842EB59E8 Q35285087-485313D9-A47E-434F-BF5A-719712358F06 Q35351684-AF2B9423-A6E2-49FE-AC8E-2BB94D28C323 Q35362251-AEA5F7E5-B072-4677-85CA-A47B1246E308 Q35598071-7C5B0C4D-53C7-4162-9BB3-B4BC98EB879C Q35852921-1E4E6F16-310E-4277-846E-513CD2EF5159 Q35887654-1293E788-55DD-476E-A10E-7B9C128DC615 Q35901957-5A1F0363-0A55-4C16-963B-967F45090933 Q35991939-428A7243-688A-4C7A-8A4A-D12242858E77 Q36050021-8FD1A59D-68E1-4039-A6C8-2C5BF4191E74 Q36100445-5024F190-47E4-4410-869D-D5E464F88C63 Q36590943-92854C9A-11E4-4867-B1FA-FE0AEA37E139 Q36602539-17AD7640-BA20-4CFD-993C-3ACE9F269D68 Q36969812-2AEB87C2-BA8D-4575-973B-080953374F63 Q37154570-B410CF14-C5D7-4CA1-88D8-5F27E795E7A5 Q37239088-FC0C560E-20FD-42D5-9869-C8F98C6FCB08 Q37243265-3F366CC7-0A77-4034-94D3-798978CB8F43 Q37435417-EB27AC38-C1F7-4561-9964-0C90B3CCAAB9 Q37547770-04A8B438-6E52-4E62-943A-1B9B304A8A7E Q37607972-9A3A93F1-44E4-4C82-BCF9-B03027A3F2FC Q37627281-6E66510F-FEE3-43F5-ABAA-764376103D36 Q38032255-D6F7DEE9-2495-4AC8-8A37-D3E17922BE12

P2860

Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes.

Item

http://www.wikidata.org/entity/Q36915945

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Unrelated donor umbilical cord ...... t on transplantation outcomes.

@en

type

Item

label

Unrelated donor umbilical cord ...... t on transplantation outcomes.

@en

prefLabel

Unrelated donor umbilical cord ...... t on transplantation outcomes.

@en

P1476

Unrelated donor umbilical cord ...... ft on transplantation outcomes

@en

P2093

Adam Mendizabal

http://www.w3.org/2001/XMLSchema#string

Deborah Semmel

http://www.w3.org/2001/XMLSchema#string

Joanne Kurtzberg

http://www.w3.org/2001/XMLSchema#string

June Allison

http://www.w3.org/2001/XMLSchema#string

Kristin Page

http://www.w3.org/2001/XMLSchema#string

Maria L Escolar

http://www.w3.org/2001/XMLSchema#string

Paul L Martin

http://www.w3.org/2001/XMLSchema#string

Paul Szabolcs

http://www.w3.org/2001/XMLSchema#string

Shelly Carter

http://www.w3.org/2001/XMLSchema#string

Sonali Lakshminarayanan

http://www.w3.org/2001/XMLSchema#string

P2860

Statistical aspects of the analysis of data from retrospective studies of disease

Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease

Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation.

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution.

Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo.

Cord-blood transplants from unrelated donors in patients with Hurler's syndrome.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling.

Lysosomal storage disorders.

P304

2979-2989

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2008-03-140830

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

Suhag Parikh

P577

2008-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5268968

http://www.w3.org/2001/XMLSchema#string

P698

18587012

http://www.w3.org/2001/XMLSchema#string

P921

patient

P932

2556628

http://www.w3.org/2001/XMLSchema#string

Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes.

about

P2860

P2860

Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932